In a complaint filed in the Eastern District of New York, 30 states have accused McKesson of repackaging leftover cancer drugs and selling them as new - all for profit and resulting in patient harm. One of the relators in this case is Omni Healthcare Inc., which provides an interesting twist. Please see link for article re: same.
Comments
There are no comments for this post. Be the first and Add your Comment below.
Leave a Comment